Africa Map

African Press Agency

African Press Agency Logo
   

 Home
 Country Profile
 Useful Links
 Contact us

Home

VaccineBack
[Published: Tuesday January 12 2021]

 How the single-shot Janssen vaccine works

 
NEW YORK, 12 Jan. - (ANA) - A Covid-19 vaccine developed in the US that may only require one dose to be effective is on track to become the third approved for use in the UK.
 
The Janssen vaccine has reached stage three of clinical trials and could soon be granted emergency authorisation - a move that could help the UK government hit its target of vaccinating a total of around 13 million people by mid-February.
 
Britain has already ordered 30 million doses of the jab, developed by pharmaceutical giant Johnson & Johnson, with the option of 22 million more. - (ANA) -
 
AB/ANA/12 January 2021 - - -
 
 

North South News website

Advertise banner

News icon US/Coronavirus
News icon UK/Coronavirus
News icon Germany/New Variant of Covid
News icon US/Congress stormed
News icon Russia/Navalny
News icon WHO/Vaccine
News icon UN/Libya
News icon UK/Virgin Islands
News icon Belarus/Ice Hokey
News icon EU/UK/Finances

AFRICAN PRESS AGENCY Copyright © 2005 - 2007